Inhibikase Therapeutics to Present at the LD Micro Invitational XIII
- Tuesday, May 30, 2023, 7:12
- PR Newswire
- Add a comment
BOSTON and ATLANTA, May 30, 2023 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease, Parkinson’s-related disorders and…
About the Author
admin has written 20652 stories on this site.